TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MERCK & CO. Share Price

Certificat

DE000SD4MA27

Real-time Boerse Frankfurt Warrants 15:28:56 03/06/2024 BST
5.7 EUR +5.36% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MERCK & CO.
1 month-8.46%
3 months-5.91%
Date Price Change
03/06/24 5.7 +5.36%
31/05/24 5.41 +1.31%
30/05/24 5.34 -3.09%
29/05/24 5.51 +0.92%
28/05/24 5.46 -4.38%

Real-time Boerse Frankfurt Warrants

Last update June 03, 2024 at 03:28 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SD4MA2
ISINDE000SD4MA27
Date issued 12/03/2021
Strike 66.89 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.28
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.17
Lowest since issue 1.05
Spread 0.01
Spread %0.18%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5 USD
Average target price
141.9 USD
Spread / Average Target
+13.01%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW